CIM INVESTMENT MANAGEMENT INC

Position in ACAD — Acadia Pharmaceuticals Inc

CIK 1179791 PITTSBURGH, PA

Position in ACAD

as of Mar 31, 2026 · filed May 19, 2026 Compact

Position Value

$316,960

-$63,363 QoQ

Shares Held

14,239

0.0% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

CIM INVESTMENT MANAGEMENT INC holds $2,638,068 across 8 Biotechnology names. ACAD ranks #4 (12.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	5,930	$558,131
2	HALO	Halozyme Therapeutics, Inc.	8,492	$548,837
3	REGN	Regeneron Pharmaceuticals, Inc.	452	$349,233
4	ACAD	Acadia Pharmaceuticals Inc This page	14,239	$316,960
5	CYTK	Cytokinetics Inc	4,678	$308,326
6	LGND	Ligand Pharmaceuticals Inc	1,484	$296,280
7	RYTM	Rhythm Pharmaceuticals, Inc.	2,993	$260,301
8			12,537	$0

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$316,960	14,239	0.0%	Shares	Sole	2026-05-19
2025-12-31	$380,323	14,239	0.0%	Shares	Sole	2026-02-17
2025-09-30	$303,860	14,239	-51.9%	Shares	Sole	2025-11-18
2025-06-30	$637,888	29,573	+100.7%	Shares	Sole	2025-08-22
2025-03-31	$244,698	14,732	-2.3%	Shares	Sole	2025-06-02
2024-12-31	$276,754	15,082	0.0%	Shares	Sole	2025-02-13
2024-09-30	$231,961	15,082	0.0%	Shares	Sole	2024-11-25
2024-06-30	$245,082	15,082	-19.2%	Shares	Sole	2024-08-15
2024-03-31	$345,208	18,670	+82.1%	Shares	Sole	2024-05-07
2023-12-31	$320,990	10,252	0.0%	Shares	Sole	2024-02-16
2023-09-30	$213,651	10,252	0.0%	Shares	Sole	2023-11-14
2023-06-30	$245,535	10,252	—	Shares	Sole	2023-08-09
No filing history on record for this holder in this stock.